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Abstract
TORC1 is a central regulator of cell growth in response to amino acid availability, yet little is known about how it is
regulated. Here, we performed a reverse genetic screen in yeast for genes necessary to inactivate TORC1. The screen
consisted of monitoring the expression of a TORC1 sensitive GFP-based transcriptional reporter in all yeast deletion strains
using flow cytometry. We find that in response to amino acid starvation, but not to carbon starvation or rapamycin
treatment, cells lacking NPR2 and NPR3 fail to fully (1) activate transcription factors Gln3/Gat1, (2) dephosphorylate TORC1
effector Npr1, and (3) repress ribosomal protein gene expression. Both mutants show proliferation defects only in media
containing a low quality nitrogen source, such as proline or ammonia, whereas no defects are evident when cells are grown
in the presence of glutamine or peptone mixture. Proliferation defects in npr2D and npr3D cells can be completely rescued
by artificially inhibiting TORC1 by rapamycin, demonstrating that overactive TORC1 in both strains prevents their ability to
adapt to an environment containing a low quality nitrogen source. A biochemical purification of each demonstrates that
Npr2 and Npr3 form a heterodimer, and this interaction is evolutionarily conserved since the human homologs of NPR2 and
NPR3 (NPRL2 and NPRL3, respectively) also co-immunoprecipitate. We conclude that, in yeast, the Npr2/3 complex mediates
an amino acid starvation signal to TORC1.
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Introduction
TheTargetofRapamycin (TOR)kinasehasemerged asa central
processing unit that can incorporate signals from diverse pathways
regarding the availability of glucose, oxygen and amino acids [1].
The TOR kinase is a large scaffolding protein-kinase that is highly
conserved in all eukaryotes. In recent years, TOR has been shown
to nucleate two different multiprotein complexes. In the TOR
Complex 1 (TORC1), TOR is associated with raptor and mLST8
(yeast Kog1 and Lst8, respectively), and its known mammalian
phosphorylation targets are p70 S6K1 and 4E-BP1 [2]. In the
phosphorylated state, both of these substrates are involved in
promoting protein translation. In the TORC2, TOR partners with
rictor (yeast Avo3), instead of raptor, and mLST8 [3,4].
Mammalian TORC2 phosphorylates AKT protein at Ser
473, but
not TORC1 substrates [5]. Interestingly, the natural compound
rapamycin only inhibits TORC1 when complexed with intracellu-
lar protein FKBP12. The inhibition of TORC1 by the treatment of
cellswithrapamycinleadsto a nutrientstarvation-like phenotype,in
cells ranging from yeast to human [6,7].
Befitting its ability to process numerous nutritional signals,
TORC1 controls a diverse set of effector pathways. In a nutrient
rich environment, TORC1 in yeast is responsible for promoting
translation initiation, ribosome biogenesis, and anabolic pathways
[8–10]. Upon nutrient limitation or rapamycin treatment, these
processes are inhibited, and the cell initiates macroautophagy,
activates enzymes necessary for catabolic processes, and ultimately
enters the G0 phase of the cell cycle [1,11]. In yeast, an active
TORC1 controls these processes by preventing several transcrip-
tion factors from entering the nucleus and activating their target
genes. In rich media, transcription factors Gln3/Gat1 are
prevented from activating enzymes necessary for nitrogen
catabolism, Msn2/4 from inducing stress response, and Rtg1/3
from activating retrograde signaling [12–14]. TORC1 controls
ribosomal protein (RP) gene expression by excluding corepressor
Crf1 from entering the nucleus and inactivating RP gene
transcription [15].
While there has been some progress in understanding how
glucose, oxygen and energy status are signaled to TORC1 [1], the
molecular mechanism by which an amino acid starvation leads to
TORC1 inactivation is unclear and controversial [16]. An amino
acid starvation, just like rapamycin treatment, leads to a rapid
dephosphorylation of the mTORC1 effectors S6K1 and 4E-BP1
[2]. This inactivation was proposed to be dependent on the
presence of tuberous sclerosis proteins TSC1 and TSC2, which
form a heterodimer and connect the insulin/IGF-IRS-PI3K-Akt
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found TSC2 to be unnecessary for this inactivation [18,19].
Further, organisms that appear to have an amino acid sensitive
TORC1, such as S. cerevisiae and C. elegans, do not have homologs
of TSC1 and TSC2. hVPS34, encoding a class III PI3-kinase, has
been shown to be required for amino acid induced phosphory-
lation of S6K1 [19], and its kinase activity correlates with amino
acid levels [20]. However, at this point it is unclear how hVPS34
regulates TORC1 [21]. If Vps34 was necessary to maintain active
TORC1, then one would expect cells lacking the VPS34 gene to
exhibit severe growth defect and mimic rapamycin treatment. Yet,
yeast vps34D cells grow normally in rich media [22], despite the
fact that Vps34 is the only PI3K found in yeast. Also, a recent
report was unable to detect defective TORC1 signaling in Vps34
mutant D. melanogaster [23].
With the hypothesis that the genes necessary to inactivate
TORC1 in response to amino acid starvation are distinct from the
Vps34 pathway and that these genes are not essential for growth
under a rich nutrient environment, we sought to screen the yeast
deletion collection for genes necessary to inactivate TORC1 in
response to amino acid starvation. We devised a GFP-based
transcriptional reporter assay where TORC1 activity can be
monitored by measuring intracellular GFP content by high
throughput flow cytometry. The screen yielded two largely
uncharacterized genes, NPR2 and NPR3, and here we demonstrate
that they form a heterodimer that is responsible for inactivating
TORC1 specifically in response to amino acid starvation.
Results
Flow cytometry–based genetic screen for regulators of
TORC1
Gene expression profiling has revealed that either rapamycin
treatment or amino acid starvation in both yeast and human cells
lead to a robust activation of genes involved in nutrient catabolism
[7,10]. In yeast, an active TORC1 complex binds and maintains
an association between a cytosolic Ure2 and two transcription
factors, Gln3 and Gat1 [24]. Upon a shift to a nitrogen free media,
or rapamycin treatment, Ure2 releases both Gln3 and Gat1, which
then move into the nucleus to activate the transcription of largely
common target genes [25]. One of the genes activated this way is
DAL80 (Figure 1A). For our genetic screen, we employed the
expression of DAL80 as a readout for the activity status of
TORC1. An active TORC1 suppresses the transcription of
DAL80 mRNA, whereas inactivation of TORC1 leads to a
transcriptional upregulation of DAL80.
To measure the Dal80 reporter in thousands of different
deletion strains, we constructed a Dal80-based GFP reporter
plasmid Dal80pr-GFP (Figure 1B). We could monitor the
expression of this reporter by flow cytometry in a high-throughput
fashion. In cells harboring this plasmid, GFP levels can be induced
by either rapamycin treatment or amino acid starvation
(Figure 1C). As DAL80 mRNA level stays constant following the
start of induction (data not shown) and GFP has a long half-life,
GFP accumulates linearly over time in the cell. As a result, this
method enabled us to identify mutants that fail to express the
reporter, as well as mutants that partially express or over-express
the reporter.
We assembled all non-essential yeast deletion strains into fifty-
five 96-well plates, such that each well contained a known deletion
strain. Each well was transformed with Dal80pr-GFP and the
hygromycin B-resistant transformants were outgrown from the
non-transformed cells in liquid media containing hygromycin B.
Even though we set out to perform our screen for mutants that fail
to induce the Dal80pr-GFP reporter in response to amino acid
starvation, we also screened the genome for mutants that (1)
activate Dal80pr-GFP in the rich media even in the absence of
rapamycin, and (2) have altered induction of Dal80pr-GFP in
response to rapamycin treatment. In summary, we screened the
Dal80pr-GFP reporter expression in ,5100 strains under three
different conditions (Figure 1D).
YPD screen: Screen for mutants with activated Gln3 and
Gat1 in rich media
In this screen, we sought to find mutants that have active Gln3
and Gat1 in the rich YPD media. It is well known that a lack of
Ure2, a cytosolic inhibitor of Gln3 and Gat1, leads to the
activation of both transcription factors even in amino acid rich
medium [12]. When we screened the genome in YPD medium,
only ure2D cells show elevated levels of the reporter expression
(Figure 2A). ace2D cells are large and clumpy, and as a result they
exhibit a higher background signal [26]. These data show that
among the non-essential deletion strains, only the ure2D mutant
leads to Gln3 and Gat1 activation in the rich media.
RAPA screen: Screen for mutants with partially- or hyper-
active Gln3 and Gat1 in the presence of rapamycin
To successfully identify the mutants that under-express and
over-express the Dal80pr-GFP reporter in a single screen, we
selected to perform the flow cytometry analysis after a 15-hour
induction in a rapamycin containing rich YPD media. We chose
the 15-hour timepoint because by then the intracellular GFP levels
were about 10 fold above background, enabling us to identify
mutants that either under-express or over-express the Dal80pr-
GFP reporter. As can be seen from Figure 2B, deletion strains that
over-express and under-express the reporter can be identified. We
re-transformed 43 mutants that over-expressed our reporter two-
fold or higher (mutants above the red line in Figure 2B), and
performed an induction time course for each mutant. Of these 43
mutants, 36 exhibited GFP levels higher than a WT strain (Figure
S1). Interestingly, in the re-analysis, the top three strains that over-
express GFP are rtg1D, rtg2D and rtg3D cells. The Rtg1–3 proteins
Author Summary
Before a eukaryotic cell commits to cell division it must be
large enough so that both daughter cells would be of
viable size. The control of cell size is largely mediated by
nutritional input signals via an evolutionarily conserved
protein complex termed TORC1. In particular, TORC1 has
been shown to sense the level of amino acids and its
activity correlates with the level of amino acids present in
the media. Yet, it is largely unknown how TORC1 senses
amino acids. Here we demonstrate that the evolutionarily
conserved Npr2/3 complex mediates the amino acid
scarcity signal to TORC1. Cells lacking NPR2 and NPR3
genes fail to inactivate TORC1 when amino acids are
scarce. Overactive TORC1 prevents these cells from
adapting to an amino acid scarce environment, and, as a
result, these cells are unable to proliferate in media that is
not rich in amino acids. Artificially inhibiting TORC1 with
rapamycin can completely rescue these defects. These
results provide insight into how cells sense amino acid
deficiency. Moreover, as deletions of NPR2 have been
implicated in tumor growth, these results offer a fertile
ground to study the role overactive TORC1 might play in
those cancers.
Npr2/3 Inactivates TORC1
PLoS Genetics | www.plosgenetics.org 2 June 2009 | Volume 5 | Issue 6 | e1000515Figure 1. A genetic screen for regulators of TORC1. (A) A schematic of the TORC1 pathway. In nutrient rich environment, TORC1 is active and
Gln3/Gat1 are in the cytoplasm. Upon TORC1 inactivation by rapamycin or amino acid starvation, Gln3 and Gat1 translocate into the nucleus, leading
to the transcriptional activation of Dal80. (B) Dal80 gene expression reporter contains 600 basepairs of Dal80 promoter driving the expression of GFP.
HygB, hygromycin B resistance gene, is used for selection of transformants. (C) Accumulation of GFP in cells is linear. Wildtype cells transformed with
Dal80pr-GFP plasmid were treated either with rapamycin (20 ng/mL) or inoculated into nitrogen free medium. At indicated timepoints the average
GFP content of the cells was determined by flow cytometry. (D) Fifty-five 96-well plates, containing all non-essential yeast deletion strains, were
transformed with the Dal80pr-GFP reporter plasmid. The cells in each plate were grown under 3 conditions: YPD for 6 hours, YPD+rapamycin for
15 hours or N-free media for 4 hours. GFP content was determined by flow cytometry.
doi:10.1371/journal.pgen.1000515.g001
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a transcriptional activation of the first three TCA cycle enzymes in
respiratory-deficient cells [27]. These findings demonstrate that
the presence of Rtg1–3 proteins suppresses the activation of Gat1
and Gln3 transcription factors in response to rapamycin treatment
and suggest that other mutants identified in this screen might be
involved in retrograde gene expression (such as prm10D cells with
the 4
th highest GFP expression).
We also reanalyzed the top 40 strains that under-expressed
Dal80pr-GFP (strains below the green line in Figure 2B). The top
three deletion strains that fail to express the reporter were as
expected: fpr1D, gln3D and gat1D strains. Fpr1 encodes the yeast
version of FKBP12 that binds rapamycin before inhibiting the
TORC1 complex, and fpr1D cells are completely rapamycin
resistant. These three strains had no detectable induction of GFP,
while the rest of the strains that lie below the green line had above-
background levels of GFP. Upon inspection of the list of strains
that only partially express Dal80pr-GFP, we noticed that many of
these deletion strains are missing genes necessary for efficient
transcription or translation. As our screen relies on efficient
transcription and translation of GFP, we devised a filter to identify
deletion strains specific to the TORC1 pathway. We constructed a
reporter plasmid similar to our Dal80pr-GFP plasmid, but used
the Gal1 promoter in lieu of the Dal80 promoter to drive the
expression of GFP (Gal1pr-GFP). In cells harboring this plasmid,
GFP can be induced by shifting the cells from glucose-containing
media to galactose-containing media. By separately transforming
the Dal80pr-GFP and Gal1pr-GFP reporter plasmids into strains
that showed partial activation of the Dal80pr-GFP reporter, and
inducing the GFP with a corresponding inducer, we were able to
separate the TORC1-specific mutants from the mutants that are
unable to express GFP efficiently (Figure 2D). For instance, fpr1D
strain fails to induce Dal80pr-GFP in response to rapamycin
treatment, yet it can efficiently upregulate GFP expression from
the Gal1pr-GFP reporter under galactose induction. From the top
forty strains with defective inductions of Dal80pr-GFP, twenty are
TORC1-specific (Figure 2D and Figure S2). The molecular basis
for failure to activate Dal80pr-GFP can be attributed to most of
these strains. The fpr1D, gln3D and gat1D deletion strains fail to
induce the reporter for reasons discussed above. Of the remaining
17 mutants, six (sod1D, ymr073cD, yml122cD, rrd1D, ppm1D and
spt8D strains) are partially rapamycin-resistant. We have recently
shown that rapamycin resistance in these strains is due to the
inability of the Fpr1:rapamycin complex to bind to TORC1 [28].
As a result, these strains fail to fully respond to rapamycin
treatment. Another seven (ede1D, ppz1D, apn1D, yor322cD, snf7D,
bck1D and slt2D strains) are rapamycin hyper-sensitive, and
presumably rapamycin treatment leads to cell death in these cells.
For instance, bck1D and slt2D cells fail to induce Gal1pr-GFP in
response to galactose induction when rapamycin is present (data
not shown).
These findings illustrate that our screen was able to capture all
major players in the pathway. Further, demonstration that we
were able to identify strains that over-express and under-express
our reporter suggests that we could identify even minor modifiers
of TORC1 in response to amino acid starvation.
Nitrogen-free screen: Identification of Npr2 and Npr3 as
necessary to activate Gln3 and Gat1 by amino acid
starvation
To identify strains that fail to inactivate TORC1 in response to
amino acid starvation, we exposed the cells harboring the Dal80pr-
GFP reporter to media lacking all sources of nitrogen for four hours.
Nitrogen-free media contains 2% glucose (as in rich YPD medium)
and all salts, vitaminsand traceelementsthat yeast cellsneed for cell
proliferation. No nitrogen source was included as yeast can
synthesize all 20 AAs de novo. This screen identified 17 strains that
have a GFP content less than 40% of the WT. By imposing the
Gal1pr-GFP filter again, we eliminated 13 strains due to their
inability to activate Gal1pr-GFP in response to galactose induction
(Figure 2D). As expected, the gln3D and gat1D strains specifically
failed to induce the Dal80pr-GFP reporter. Lastly, npr2D and
yhl023CD strains fail to induce the Dal80pr-GFP reporter,
suggesting that proteins encoded by NPR2 and YHL023C are
involved in signaling the absence of amino acids to TORC1. For
reasons that will become clear in next sections, we renamed
YHL023C locus NPR3. NPR stands for Nitrogen Permease
Regulator, as Npr1 and Npr2 have been shown to regulate amino
acid transport activity [29,30]. Both NPR2 and NPR3 are largely
uncharacterized genes. npr2D cells were isolated as unable to grow
inthepresenceoflowconcentrationsofaminoacids[29],and NPR3
was shown to be necessary for sporulation [31]. Both genes are
conserved among all eukaryotes, yet nothing is known about their
function. A bioinformatic analysis is also unable to predict an
activity/function for either protein. We characterized these two
proteins further.
Npr2 and Npr3 are amino acid specific regulators of
TORC1
To verify that Npr2 and Npr3 are involved in activation of Gln3
and Gat1, we monitored the translocation of Gat1 into the nucleus
when npr2D and npr3D cells are shifted from the rich YPD medium
to the nitrogen-free medium. Consistent with data from the screen,
genomically GFP-tagged Gat1 fails to translocate into the nucleus
upon nitrogen starvation in npr2D and npr3D cells (Figure 3A). In
fact, while about 90% of WT cells exhibited nuclear Gat1 only
about 20% of npr2D and npr3D cells had any nuclear Gat1
(Figure 3B). Further, the npr2D npr3D double mutant behaved
exactly as either single mutant, suggesting that Npr2 and Npr3 lie
in the same pathway. These data confirm that Npr2 and Npr3 are
involved in translocation of TORC1-responsive transcription
factor Gat1, and that their absence is not suppressing the
transcription or translation of our Dal80pr-GFP reporter.
If Npr2 and Npr3 are indeed upstream regulators of TORC1,
then TORC1 in npr2D and npr3D cells should be sensitive to
rapamycin and insensitive to nitrogen starvation. Consistent with
the results from the screen, Dal80pr-GFP cannot be activated in
Figure 2. An identification of Npr2 and Npr3 as TORC1 regulators. (A) Average GFP content was determined for each strain after growth in
YPD medium. As plates were screened at different days, each strain was compared to the median GFP intensity of its 96-well plate. Cells that over-
express Dal80pr-GFP have a GFP reading over 100%, and vice versa. (B) Same as in (A), except Dal80pr-GFP was monitored after 15 hour growth in
YPD medium containing 20 ng/mL of rapamycin. Strains above the red line have a GFP content more than twice the plate median, and strains below
the green line have GFP content 60% or less than the plate median. (C) Same as in (A), except Dal80pr-GFP was monitored after 4 hour growth in N-
free medium, which lacks all sources of nitrogen and amino acids. (D) Venn diagram of strains that fail to induce Dal80pr-GFP in response to
rapamycin treatment and N-free exposure. To eliminate strains that are generally inefficient at GFP expression, the expression of Gal1pr-GFP was
monitored in all strains that failed to induce Dal80pr-GFP (see text for details).
doi:10.1371/journal.pgen.1000515.g002
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reporter can be readily activated by rapamycin in both mutants
(Figure 3C). These data posit Npr2 and Npr3 upstream of
TORC1.
To confirm that Npr2 and Npr3 mediate the amino acid
starvation signal to TORC1, we examined the effect of nitrogen
starvation in npr2D and npr3D cells on different TORC1 readouts.
TORC1 has been shown to control the phosphorylation status of
Npr1, a protein kinase that controls the post-Golgi sorting of
amino acid permeases [32]. In rich media Npr1 is hyperpho-
sphorylated, whereas nitrogen starvation or rapamycin treatment
leads to a faster migrating dephosphorylated form [30,33].
Consistent with our hypothesis, cells missing NPR2 or NPR3 are
unable to dephosphorylate Npr1 upon nitrogen starvation
(Figure 3D). Yet, inclusion of rapamycin in rich YPD media leads
to a dephosphorylation of Npr1 in both mutants. To more clearly
define the signal that both mutants fail to heed, we determined the
Npr1 phosphorylation state in cells grown with either 10 mM
proline or 10 mM glutamine as the sole nitrogen source. The
wildtype cells grown in proline media exhibited dephosphorylated
Npr1, whereas wildtype cells grown in glutamine media showed a
hyperphosphorylated Npr1 that is indistinguishable from npr2D
and npr3D cells. To our surprise, wildtype cells grown in the
presence of high concentrations of ammonia never exhibited the
same level of hyperphosphorylated Npr1 as npr2D and npr3D cells.
Even at 50 mM ammonium sulfate, wildtype cells exhibited a
faster migrating band of Npr1 than either mutant. This suggests
that ammonia itself is not sensed by Npr2 and Npr3, but rather the
signal about the levels of amino acids, such as glutamine, is
mediated to TORC1. That is, npr2D and npr3D cells, irrespective
of the nitrogen source, exhibit an Npr1 phosphorylation state
similar to the phosphorylation state of wildtype cells grown in
glutamine containing media. Therefore, the absence of NPR2 or
NPR3 appears to mimic the presence of glutamine, even if a low
quality nitrogen source is provided instead.
To further confirm the nature of the signal that npr2D and npr3D
mediate to TORC1, we examined the effect of total carbon
starvation in npr2D and npr3D cells on Npr1 phosphorylation. The
carbon starvation leads to a rapid dephosphorylation of Npr1 in
both mutants, suggesting that amino acid starvation and carbon
starvation are distinct signaling inputs to TORC1. These data
confirm that Npr2 and Npr3 mediate the signal about amino acid
starvation to TORC1.
As TORC1 exerts an exquisite control over the transcription of
ribosomal protein (RP) genes, we were interested whether amino
acid starvation is able to downregulate RP gene expression in the
two mutants. Ribosome biosynthesis is very energy expensive, and
RP genes are responsible for ,50% of the total Pol II transcription
initiation events [34]. Hence, an overproduction of RP mRNA can
be very costly for starving cells as it depletes valuable energy
resources. To study the effect of nitrogen starvation on gene
transcription, we performed a whole genome microarray exper-
iment where we shifted WT, npr2D or npr3D cells from YPD media
to N-free media for 30 minutes. For each gene, an induction ratio
was calculated by dividing the expression of that gene after the
shift in media by its expression in YPD media. Genes that are
downregulated upon the shift in media have an induction ratio
below 1, and vice versa. As can be seen in Figure 4A, mRNA
species encoding large and small ribosomal protein subunits (RPL
and RPS, respectively, highlighted in red) are downregulated less
in npr2D cells than in WT cells. (Data from npr3D data is identical
to npr2D data and is therefore not shown). In fact, this effect
appears to scale linearly, such that on average, the RP mRNA
levels are ,2.5 times higher in npr2D and npr3D cells than in WT
cells in N-free media (Figure 4B). No difference in expression was
observed in rich YPD media. Independent semi-quantitative RT-
PCR analysis on representative RPL and RPS genes confirmed
the microarray results (Figure 4C). Based on the Npr1 phosphor-
ylation data, we speculated that RP genes would exhibit a higher
expression in npr2D and npr3D cells when grown in proline or
ammonium sulfate as a nitrogen source, whereas no difference
would be observed when cells are grown in the presence of
glutamine. Indeed, both mutants exhibited a 2–3 fold higher
expression of RP genes when grown in the presence of proline as a
nitrogen source (Figure 4D). Congruent with the Npr1 phosphor-
ylation data, no difference was observed between the two mutants
and WT cells when they were grown in media containing
glutamine or 2% peptone. npr2D and npr3D cells grown in 0 mM,
1 mM or 50 mM ammonium sulfate consistently exhibited a 2–3
fold higher level of RP gene expression than WT cells (Figure 4E).
Again, it appears that npr2D and npr3D cells grown in a proline or
ammonia containing media are incapable of inactivating TORC1.
As cells grown on ammonia are known to activate retrograde
signaling pathway by activating TORC1 responsive transcription
factors Rtg1/3, we sought to determine whether npr2D and npr3D
cells are capable of inducing the expression of the Rtg1/3 target
gene CIT2 [35]. As expected, the activation of CIT2 mRNA was
greatly diminished in the two mutant strains.
In conclusion, we examined four independent TORC1 effector
pathways to confirm the effect of Npr2 and Npr3 on TORC1.
Gat1 nuclear translocation, Npr1 phosphorylation, RP gene
expression profiling and Rtg1/3 reporter expression analysis
confirm that Npr2 and Npr3 are necessary to inactivate TORC1
by amino acid starvation. In particular, npr2D and npr3D cells fail
to inactivate TORC1 when a non-preferred amino acid source is
presented. As TORC1 is a key player in a cell’s response to
nutrient availability, we hypothesized that cells lacking NPR2 and
NPR3 would fail to adapt to an environment containing non-
glutamine based nitrogen source.
Due to overactive TORC1, cells missing NPR2 and NPR3
fail to adapt to an amino acid scarce environment
To address the in vivo function of Npr2 and Npr3, we first sought
to determine the ability of cells lacking NPR2 or NPR3 to
proliferate in an environment containing low amounts of preferred
nitrogen. In our previous experiments, we noticed that npr2D and
npr3D cells do not appear to have any growth defects in rich YPD
media. Quantitatively measuring the doubling time during an
Figure 3. Npr2 and Npr3 proteins mediate the inactivation of TORC1 by amino acid starvation. (A) Genomically GFP-tagged Gat1 strains
were grown in the YPD medium, and then shifted to N-free medium for 30 minutes. Gat1 localization was observed in the indicated strains by
fluorescence microscopy. (B) Quantification of cells with nuclear GFP signal from (A). (C) Monitoring the expression of Dal80pr-GFP in npr2D and
npr3D cells after a shift to N-free media and after rapamycin induction. (D) TORC1 effector Npr1 is dephosphorylated in npr2D and npr3D cells upon
rapamycin treatment and carbon starvation but not upon nitrogen starvation. Genomically HA-tagged Npr1 strains were grown in YPD, treated with
50 ng/mL of rapamycin or transferred to N-free media for 30 minutes (upper left). YPD cultures were shifted to N-free media supplemented with
10 mM proline or 10 mM glutamine (upper right), or they were shifted to N-free media supplemented with indicated concentrations of ammonium
sulfate (lower left) for 30 minutes. Cultures were grown on YPD or YP(- dextrose) for 30 minutes (lower right). The phosphorylation state of Npr1 was
determined by Western blotting.
doi:10.1371/journal.pgen.1000515.g003
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(Figure 5A). Next, we grew prototrophic npr2D and npr3D cells in
N-free media supplemented with 2% peptone, 10 mM proline,
10 mM glutamine or increasing concentrations of ammonia.
Consistent with our molecular TORC1 activity data, npr2D and
npr3D cells grown in the presence of peptone and glutamine do not
exhibit a proliferation defect. However, when the same cells are
provided with proline or ammonia as a nitrogen source, both
mutants proliferate slowly. These data suggest that the inability to
inactivate TORC1 in both mutants leads to a failure to adapt to
an environment with a scarce source of preferred amino acids. In
all cases, the double mutant behaves exactly as the single mutants,
further confirming that Npr2 and Npr3 lie in the same pathway
upstream of TORC1. Consistent with the finding that Npr2 and
Npr3 are responsible for inactivating TORC1 only in response to
amino acid starvation, all three mutants behave exactly as WT
cells when limited for glucose (Figure S3) or grown on a non-
fermentable carbon source (data not shown).
We next sought to establish a role for Npr2 and Npr3 in the
activation of amino acid transporters. TORC1 inactivation leads
to a robust transcriptional activation of various amino acid
permeases [10]. In our unpublished studies, we have found that
threonine uptake is particularly sensitive to the presence of a
preferred nitrogen source and we sought to examine the ability of
npr2D and npr3D cells to import radiolabeled Thr. We grew cells in
either proline or glutamine and measured their Thr uptake. The
cells grown in glutamine exhibit a barely detectable uptake of Thr,
with no difference between WT and the two mutants (Figure 5B).
The cells grown in proline exhibit a robust increase in Thr uptake
activity, but this activity is about 50% of WT levels in npr2D and
npr3D cells. Therefore, npr2D and npr3D cells fail to fully activate
threonine amino acid transporters under amino acid limitation.
A long-term characteristic of nitrogen-starved yeast is their
ability to undergo sporulation, and this phenotype has been linked
to TORC1 [36,37]. In fact, a large-scale study has implicated
Npr3 in sporulation [31]. Our study confirmed this report and
here we show that npr2D cells also undergo sporulation much less
efficiently than WT cells (Figure 5C).
Lastly, as the phenotypes associated with a lack of Npr2 and
Npr3 are due to the failure to inactivate TORC1, we wondered
whether artificially inhibiting TORC1 in npr2D and npr3D cells
might rescue the proliferation defects observed in these cells under
nitrogen limitation. When npr2D and npr3D cells are shifted from
rich YPD media to nitrogen limitation media containing 0.5 mM
ammonium sulfate, three unique phenotypes can be observed.
First, in both mutants about 40% of cells undergo lysis within the
first 10 hours (Figure 5D). Second, npr2D and npr3D cells resume
logarithmic proliferation after about 12 hours, whereas WT cells
do this in about 2 hours. Third, the maximum cell density of npr2D
and npr3D cultures is about 50% of WT levels. Remarkably, all
three phenotypes can be completely rescued by including
rapamycin in the nitrogen limitation media. In other words, the
phenotypes associated with a lack of NPR2 and NPR3 genes can be
completely abolished by artificially inhibiting TORC1.
These data clearly demonstrate that Npr2 and Npr3 are
responsible for mediating the signal about amino acid starvation to
TORC1 and that TORC1 remains active in npr2D and npr3D cells
when preferred amino acid source (e.g. glutamine) is absent. As a
result, these cells fail to adapt and thrive in an environment where
nitrogen source is scarce or non-preferred. Our data also suggest
that both proteins are specific for amino acid starvation, with no
relevance in mediating the signal about carbon limitation. Lastly,
the genetic data demonstrate that both proteins act in the same
pathway upstream of TORC1.
Npr2 and Npr3 form an evolutionarily conserved
complex
To better understand the role of Npr2 and Npr3 in cells, we
purified both proteins by tandem affinity purification (TAP)
expressed under the endogenous promoters [38]. Both proteins are
relatively scarce in cells, especially Npr2. When we ran the two
purifications in adjacent lanes we noticed a single unique band
where Npr2 runs in the Npr3-TAP lane, and a single unique band
where Npr3 runs in the Npr2-TAP lane (Figure S4). This
suggested to us that Npr2 and Npr3 might be forming a
heterodimer and we sought to verify this interaction by co-
immunoprecipitation. By employing a strain with a genomically
incorporated HA-tag at the C-terminus of Npr3 and a myc-tag at
the C-terminus of Npr2, we find that when Npr3 is immunopre-
cipitated with anti-HA antibodies these immunoprecipitates
contain Npr2-myc (Figure 6A). This interaction is not medium-
dependent, as it occurs in the medium made of either YPD or N-
free media. There is a decrease in the amount of Npr2 pulled
down, but this appears to be due to degradation of Npr3. The
finding that Npr2 and Npr3 form a complex is consistent with the
observation that npr2D, npr3D and npr2D npr3D cells have identical
phenotypes with respect to amino acid starvation.
A homology search of Npr2 and Npr3 shows that both are
conserved eukaryotic-specific proteins (Figure 6B and Figure S5),
and their homologs are uncharacterized. The yeast Npr2 shares
30% identity with human NPRL2 (Npr2 Like), and the yeast Npr3
shares 19% identity with human C16orf35 (Accession number
Q12980; termed NPRL3 here). If the human homologs are
orthologous to yeast Npr2 and Npr3, then NPRL2 and NPRL3
should also form a complex in human cells. To verify this, we co-
transfected HA-NPRL2 with three N-terminally myc-tagged
proteins: XMis12 (an unrelated Xenopus protein), c-tubulin (an
unrelated human protein) and NPRL3. Upon immunoprecipita-
tion with anti-myc antibodies, only NPRL3 immunoprecipitates
contained HA-NPRL2, demonstrating that NPRL2 and NPRL3
also form a complex. The conserved nature of this complex
Figure 4. npr2D and npr3D cells fail to repress RP gene expression when grown in a non-preferred nitrogen source. (A) Gene
expression profile of WT and npr2D cells shifted from YPD to N-free media. For each gene, a fold change in expression from YPD media to 30 minutes
in N-free media is plotted. This ratio for WT cells is plotted in the X-axis and the same ratio for npr2D is plotted in the Y-axis. Identical results were
obtained with npr3D. The expression of large and small ribosomal protein genes, RPL and RPS, respectively, is in shown in red. (B) Relative level of RP
gene expression with respect to WT. The expression of each RP mRNA in npr2D and npr3D cells was compared to the level of its expression in WT cells
and the average ratio is shown. Note the higher expression of RP genes in npr2D and npr3D cells in N-free media and similar expression in YPD media.
(C) Quantitative RT-PCR of RPL and RPS mRNA. Total RNA was isolated from WT, npr2D and npr3D cells grown in either YPD or N-free media and the
expression was determined by RT-PCR. Each mRNA was quantitated with respect to WT cells grown in N-free media. (D) Quantitative RT-PCR was
performed on cells grown in N-free media supplemented 10 mM proline, 10 mM glutamine or 2% peptone. Each mRNA was quantitated with respect
to WT cells grown in 10 mM glutamine media. (E) Quantitative RT-PCR was performed on cells grown in N-free media supplemented with 0, 1 or
50 mM ammonium sulfate. Each mRNA was quantitated with respect to WT cells grown in 50 mM ammonium sulfate.
doi:10.1371/journal.pgen.1000515.g004
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ammonia containing media, but not in glutamine or peptone containing media. The cells were grown in media with indicated concentrations of
nitrogen source, and the doubling time was determined from an exponential growth phase. Asterisk denotes a difference of p,0.01 compared to WT
(determined by Student t-test). (B) A poor nitrogen source, such as proline, fails to fully activate threonine uptake in npr2D and npr3D cells. The cells
were grown on either 5 mM Pro or 5 mM Gln as a nitrogen source for 4 hours, upon which time radiolabeled Thr uptake was measured. Asterisk
denotes a difference of p,0.01 compared to WT (determined by Student t-test). (C) npr2D and npr3D cells exhibit a delayed and lower sporulation
efficiency upon nitrogen starvation. Asterisk denotes a difference of p,0.01 compared to WT (determined by Student t-test). (D) TORC1 inhibition by
rapamycin rescues npr2D and npr3D phenotypes associated with nitrogen limitation. YPD grown prototrophic cells were shifted to N-free media
supplemented with 0.5 mM ammonium sulfate with or without 20 ng/mL of rapamycin, and their proliferation was monitored by optical density
measurements. Note the cell lysis, delayed proliferation start and lower saturating cell concentrations in npr2D and npr3D cell cultures, all of which
can be rescued by inclusion of rapamycin in the media. Asterisk denotes a difference of p,0.01 compared to WT (determined by Student t-test).
doi:10.1371/journal.pgen.1000515.g005
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further studies are needed to verify this hypothesis.
Discussion
In this study we aimed to systematically screen the yeast genome
for genes necessary in sensing amino acid starvation. To achieve
this goal, we first established a robust flow cytometry-based assay
to monitor the expression of a TOR-sensitive transcriptional
reporter. We believe a GFP-based readout has three advantages
over a luciferase-based readout: (1) by employing GFP, there is no
need to lyse cells; (2) a fluorescence reading can be obtained for
each individual cell, thereby abolishing the need to normalize the
signal for the number of cells; and (3) this assay offers a possibility
of more complicated analyses with sub-populations of cells, such as
by co-induction of two different fluorescent proteins. Compared to
assays where the plate could be scanned, however, performing
flow cytometry in a high throughput manner is still time-
consuming. It takes about 45 minutes to process each 96 well
plate, with the majority of time spent flushing the fluidics system
between samples.
Using this assay, we found an evolutionarily conserved Npr2/3
complex that is responsible for the inactivation of TORC1 in
response to amino acid limitation. In response to amino acid
Figure 6. Npr2 and Npr3 are evolutionarily conserved and their orthologues interact in yeast and human cells. (A) Npr2 and Npr3 form
a nutrient insensitive complex in yeast. A genomically tagged Npr2-myc and Npr3-HA strain was immunoprecipitated with anti-HA antibodies, and
the immunoprecipitates were analyzed by Western blotting with anti-HA and anti-myc antibodies. (B) Protein sequence alignment between yeast
Npr2 and human NPRL2, and between yeast Npr3 and human NPRL3. 3 indicates identity, 2 strong similarity, 1 weak similarity and 0 no similarity. (C)
NPRL2 and NPRL3 interact in human cells. HA-NPRL2 was cotransfected into HeLa cells with myc-XMis12, myc-c-tubulin or myc-NPRL3 for 2 days.
Myc-fusion proteins were immunoprecipitated with anti-myc antibodies, and the immunoprecipitates were analyzed by Western blotting with anti-
HA- and anti-myc antibodies. (D) A proposed model for Npr2/3. When the cells encounter an environment with limited availability of preferred amino
acids (e.g. glutamine), the cells adapt to the new environment by decreasing the TORC1 activity via the action of the Npr2/3 complex. Npr2/3
complex does not appear to play a role in signaling the presence of abundant amounts of amino acids or glucose limitation.
doi:10.1371/journal.pgen.1000515.g006
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inactivate such TORC1 readouts as Npr1 phosphorylation, Gat1
inhibition and ribosome biosynthesis. Correspondingly, these cells
are unable to adjust to a growth environment where the nitrogen
source is limiting or of poor quality. Our data appear to indicate
that the Npr2/3 complex specifically mediates a signal about the
low quality/quantity of amino acids since phenotypes associated
with NPR2/3 deletion are evident only when cells are grown on
nitrogen sources that are sub-optimal for TORC1 activity. For
instance, when cells are grown with peptone or glutamine as
nitrogen sources, TORC1 is fully active and under those
conditions npr2D and npr3D cells do not exhibit proliferation
defects. Under conditions where a lower activity of TORC1 is
required, such as in the presence of proline or ammonia, Npr2/3
are responsible for lowering this activity. In the simplest model, the
Npr2/3 complex senses the levels of glutamine and inactivates
TORC1 when those levels are low. Further studies must
determine whether the Npr2/3 complex is itself responsible for
sensing intracellular amino acid pools or whether this complex
simply mediates the signal. Interestingly, our results indicate that
neither protein plays a role in carbon starvation, since in both
mutants TORC1 is inhibited when glucose is removed from the
media and both mutants proliferate normally under glucose-
limiting conditions (Figure 6D).
Despite the high degree of conservation, our best efforts to assign
an activity or function to either Npr2 or Npr3 were unsuccessful, as
neither protein exhibits characteristic domain structures that could
predict their cellular function. Our efforts to co-immunoprecipitate
TORC1 and Npr2/3 were inconclusive (data not shown). Also, the
Tor1/Kog1 complex was unaltered in npr2D and npr3D cells (data
not shown). Further complicating analysis of both proteins is their
relatively low abundance in the cell. In fact, in our hands human
NPRL2 is detectable in only a few cell lines (data not shown). This
has hindered our attempts to purify additional members of the
complex, as well as visualize their sub-cellular location. Clearly,
furtherbiochemicaland geneticapproachesareneededtoshedlight
on the mechanistic aspects of their function.
Recently, two groups characterized a role Rag GTPases play in
activating TORC1 by amino acids in human tissue culture cells
and D. melanogaster [39,40]. These studies demonstrated that Rag
GTPases are part of the extended TORC1 complex and that cells
expressing constitutively active RagA/B fail to inactivate TORC1
when amino acids are withdrawn. Interestingly, Rag A and RagB
are similar to each other and they appear to be orthologus to yeast
Gtr1. If yeast Gtr1 was responsible for activating TORC1, then
deletion of GTR1 should lead to lethality or at least mimic a
rapamycin-like slow proliferation phenotype. Yet, gtr1D cells
appear normal and don’t express the TORC1-sensitive Dal80pr-
GFP reporter in rich media (data not shown). This discrepancy
could be explained by either a substitution of Gtr1 by another
GTPase in yeast, or by a divergence of the amino acid signaling
pathway to TORC1 between metazoans and yeast. By a similar
token, yeast Vps34 did not emerge from our screen as a regulator
of TORC1 (see Introduction). Further studies must examine the
role of Rag GTPases in lower eukaryotes and whether the Npr2/3
complex is functionally conserved in higher eukaryotes. Keeping
with the conserved nature of TORC1 and its regulation by amino
acids, it would be exciting if a unifying mechanism emerges.
Except for mTOR itself, many of the upstream and downstream
components of the mTOR pathway are known to be either proto-
oncogenes or tumor suppressors [1]. Interestingly, early reports
have implicated NPRL2 as a tumor suppressor gene. NPRL2 is
located on the human chromosome 3p21.3 homozygous deletion
region [41], a region that is deleted in various human cancers [42].
Further, reintroduction of NPRL2 into these cells inhibits cell
proliferation both in cell lines and in human lung cancer mouse
models [43,44]. Human NPRL2-null cells and yeast npr2D cells
both have been shown to exhibit resistance to cisplatin [44],
suggesting functional conservation and raising the possibility that
NPRL2 might act as a repressor of mTORC1. It remains to be
determined whether a mutation in NPRL2 is truly the driver
mutation that gives rise to neoplastic growth via overactive
mTORC1, but a high mTORC1 activity has certainly been
ascribed to invasive tumors [45]. Further, as cancer cells with
hyperactive mTORC1, either due to loss of PTEN or TSC1/2,
have been shown to be particularly sensitive to rapamycin
treatment [46,47], we speculate that cancer cells with mutated
NPRL2 might also be particularly sensitive to rapamycin. Also,
since both Npr2 and Npr3 are necessary for inactivation of
TORC1 in yeast, it would be interesting to examine whether a
deletion of human NPRL3 also correlates with tumorigenesis.
In conclusion, here we report the discovery of a novel, conserved
Npr2/3 complex that specifically inactivates TORC1 in response to
amino acid limitation in yeast. Inactivation of TORC1 is important
for adaptation to an environment with scarce amino acids, since
diminished TORC1 activity leads to activation of amino acid
permeases and catabolic enzymes, repression of ribosomal protein
gene expression, and induction of macroautophagy. Cells lacking
NPR2 or NPR3 are unable to inactivate TORC1, and they fail to
thrive in nitrogen challenged environment as a result. These results
demonstrate a unique way by which the cells respond to nutrient
limitation, and this complex provides a fertile ground to study the
regulation of this important pathway.
Materials and Methods
Strains, media, and plasmids
The genetic screen was conducted with diploid yeast deletion
collection [48]. A strain with genomically integrated GFP at the C-
terminus of Gat1 has been described [49]. For Gat1-GFP studies,
this strain served as the wildtype. From that strain, NPR2 was
deleted using the kanMX cassette and NPR3 was deleted using the
hygromycin B-phosphotransferase cassette from pAG26 plasmid.
The double mutant strain was created by deleting NPR3 from Gat1-
GFP npr2D strain. Npr1, Npr2 and Npr3 were epitope tagged at the
C-terminus with PCR products amplified from pFA6a-3HA-
kanMX6, pFA6a-13myc-His3MX6 and pFA6a-3HA-kanMX6,
respectively [50]. YPD media consists of 1% yeast extract, 2%
peptone and 2% glucose. N-free media consists of 0.17% Yeast
Nitrogen Base without amino acids and ammonium sulfate (Sigma)
and 2% dextrose. Carbon-free media consists of 1% yeast extract
and 2% peptone. All yeast experiments were carried out at 30uC.
The GFP expression-reporter vectors, with added hygromycin B-
phosphotransferase and GFP genes, are based on pRS426, a
multicopy 2m-based plasmid. Six hundred basepairs of Dal80 or
Gal1 promoter was fused in-frame with GFP to obtain the final
Dal80pr-GFP or Gal1pr-GFP, respectively. NPRL2 and c-tubulin
were amplified from ProQuest cDNA library (Invitrogen). Full
length NPRL2 (380 AA) was cloned into pCS-HA vector. NPRL3
was amplified from Mammalian Gene Collection clone MGC2816.
This isoform is missing the first 179 amino acids from the amino
terminus and is therefore 390 amino acids long. Both c-tubulin and
NPRL3 were cloned into pCS-myc vector. Xmis12-myc was a kind
gift from Aaron Straight (Stanford).
Yeast deletion collection transformation
All non-essential yeast deletion strains were distributed over
fifty-five 96-well plates such that each strain was in a designated
Npr2/3 Inactivates TORC1
PLoS Genetics | www.plosgenetics.org 12 June 2009 | Volume 5 | Issue 6 | e1000515well. The strains were grown in 150 mL of YPD to saturation at
30uC on orbital shakers. 450 mL of fresh YPD media was added
and the cells were allowed to enter a logarithmic growth phase.
After 3 hours, the cells were pelleted by centrifugation of the plate
at 750 g and the media was poured out without disturbing the cell
pellet. To each well, 250 mL of the transformation mixture (36%
polyethylene glycol, 0.1 M lithium acetate, 100 mg of salmon
sperm DNA, and 5 mg of plasmid DNA) was added. The cell pellet
and transformation mixture were mixed by shaking. The plates
were incubated at 30uC for one hour, followed by a heat shock at
42uC for 45 minutes. The cells were then pelleted by centrifuging
the plate at 750 g, the transformation mixture was poured out, a
fresh 300 mL of YPD media was added, and the cells were allowed
to express the hygromycin B-phosphotransferase protein by
shaking the plates at 30uC. After 1.5 hours of growth, 300 mLo f
YPD with 26hygromycin B was added. The final concentration
of hygromycin B in 600 mL of YPD was 300 mg/mL. The cells
were grown with shaking for 2 days, after which 5 mL of cells were
transferred to a new 600 mL of YPD with hygromycin B. Cultures
were grown for 24 hours and stored at 4uC until use. About 98%
of wells showed growth after reinoculation. Usually, about 10
plates were transformed in parallel.
GFP content determination by flow cytometry
15 mL of transformed cells were allowed to recover for 6 hours
in 450 mL of YPD at 30uC with shaking. The plasmid selection
was maintained by including hygromycin B in the medium. After
6 hours, 10 mL of cells were transferred to 190 mL of PBS with
cycloheximide (to prevent non-specific induction of GFP). These
plates were used for ‘‘YPD Screen’’. Another 20 mL of recovered
culture was transferred to an YPD culture containing 20 ng/mL of
rapamycin and hygromycin B. These plates were grown for
15 hours with shaking at 30uC. After 15 hours, 10 mL of the
rapamycin culture was transferred to 190 mL of PBS with
cycloheximide. These plates were used for ‘‘RAPA Screen’’. The
remaining 430 mL of recovered cells were pelleted, washed with
PBS once, and inoculated in 450 mL of N-free media. These 96-
well plates were incubated at 30uC with shaking for 4 hours, after
which 10 mL of cells was transferred to 190 mL of PBS with
cycloheximide. These plates were used for ‘‘N-free Screen’’. All
flow cytometry readings were conducted on the Guava PCA-96
AFP system (Guava Technologies, Hayward, CA). For each well,
500 cells were analyzed and the average GFP fluorescence was
noted. It typically took 40 minutes for the flow cytometer to
process one 96-well plate.
Gat1 localization
The WT, npr2D, npr3D and npr2Dnpr3D cells, all with
incorporated Gat1-GFP, were grown in the YPD medium in
early logarithmic growth phase. For the N-free media analysis, the
strains were pelleted, washed quickly with N-free media and
inoculated in fresh N-free media for 30 minutes. For the YPD
analysis, the strains grown in YPD were pelleted, washed with PBS
once and inoculated in fresh PBS. The GFP signal was imaged
directly by fluorescence microscopy.
Npr1 phosphorylation detection
Twenty five milliliters of YPD-grown cells (OD600=1) were
pelleted by centrifugation, washed once with water and inoculated
into 25 mL of indicated media for 30 minutes. The cells were
pelleted by centrifugation and frozen. One milliliter of lysis buffer
(PBS/1 mM EDTA/1% NP-40) with protease inhibitors (2 mg/
mL aprotinin, 2 mg/mL leupeptin, 1 mM PMSF, 1 mM benza-
midine) and phosphatase inhibitors (10 mM sodium fluoride,
2 mM sodium vanadate, 5 mM sodium pyrophosphate, 10 mM b-
glycerophosphate) was used to resuspend the frozen cell pellet.
The cell mixture was transferred to 15 mL Falcon tube containing
400 mL of glass beads (500 mm in diameter, Sigma). The tubes
were vortexed at 4uC for 10 minutes. Supernatants were collected
after centrifugation at 750 g for 5 min at 4uC, followed by another
centrifugation at 10,000 g for 10 minutes at 4uC. The total protein
lysate was normalized by Bradford assay, and 50 mg of protein was
loaded onto 8% Bis-Tris gel (Invitrogen). The resolved lysate was
transferred to a nitrocellulose membrane and probed with anti-HA
antibodies. HRP-labeled secondary antibodies were detected by
ECL detection kit (Amersham).
[
3H]-Thr uptake assay
Indicated prototrophic haploid cells were grown for 4 hours in
media containing 2% glucose and 0.17% Yeast Nitrogen Base w/o
amino acids and ammonium sulfate, supplemented with either
5 mM proline or 5 mM glutamine. One tenth OD600 units of cells
(corresponding to ,2 million cells) was washed with media
containing 2% glucose and 0.67% Yeast Nitrogen Base w/o
amino acids. Cells were inoculated in 7.5 mL of this media and
2.5 mCi of [
3H]-Threonine (Amersham) was added. At indicated
timepoints, 1 mL of cells was vacuum filtered onto nitrocellulose
filters (Whatman glass microfiber filters, diameter 25 mm) and
washed twice with 5 mL of PBS. Retained radioactivity was
determined by liquid scintillation method. After the last timepoint,
OD600 was determined and it never differed more than 5%
between cultures. Blank sample contained 1 mL of vacuum
filtered and washed cells without radioactivity.
Sporulation efficiency determination
Indicated diploid cells from the deletion collection were grown
in YPD plates for 24 hours. They were then inoculated into 1%
potassium acetate solution, and the percentage of cells that had
undergone sporulation was determined by microscope.
Microarray analysis
Indicated prototrophic haploid cells were grown in 150 mL of
YPD to OD600=0.5. For N-free samples, YPD cultures were
pelleted, washed once with N-free media, and inoculated into
150 mL of N-free media for 30 minutes. Cultures were quickly
spun down and cells stored at 280uC until use. mRNA isolation,
cDNA synthesis and labeling, and array processing was done as
previously described [51]. For ribosomal protein gene expression
analysis, all RPL and RPS genes were included in the analysis.
Reverse transcriptase (RT)–PCR
Total RNA was prepared by the same protocol as for the
microarray experiment. Twenty micrograms of total RNA was
treated with 1 U of DNase (Invitrogen) for 15 min at room
temperature. Following heat denaturation at 65uC for 10 min, RT
using SuperScript II was performed as recommended by the
manufacturer (Invitrogen). One twentieth of the reaction was used
for PCR. Thermal cycling was carried out for 20 cycles at 94uC for
20 s, 58uC for 20 s and 68uC for 45 s. For transcripts not visible at
20 cycles, 25 cycles of PCR was performed. The primer sequences
were designed to distinguish A and B versions of RP mRNA.
Yeast co-immunoprecipitation
Cell lysate was prepared as described for Npr1 phosphorylation
detection. Five milligrams of total protein in 1 mL was used for
immunoprecipitation experiments. Five micrograms of rabbit anti-
HA antibody was added and immunocomplexes were allowed to
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slurry of protein A-agarose was then added and incubated another
2 hours. Agarose beads were washed with lysis buffer (without
protease inhibitors) four times and the beads were boiled in LDS
Sample Buffer (Invitrogen) for 2 minutes. Immunoprecipitates
were resolved by SDS-PAGE, transferred to a nitrocellulose
membrane and probed with indicated antibodies.
Mammalian tissue culture and co-immunoprecipitations
HeLa cells were grown in DMEM, supplemented with 10%
fetal bovine serum. At 60% confluency, 10-cm plates of cells were
transfected with indicated constructs using FuGene transfection
reagent (Roche). After 48 hours cells were washed with PBS and
lysed in 1 mL of lysis buffer (PBS/1 mM EDTA/40 mM
HEPES/1% NP-40) with protease inhibitors. Lysates were first
cleared with a spin at 10,000 g for 5 min and then precleared with
one-hour incubation with agarose G beads. One milligram of total
cell lysate was used for immunoprecipitation with one microgram
of mouse anti-myc antibody as described above for yeast.
Supporting Information
Figure S1 Identification of strains over-expressing Dal80pr-GFP
reporter. Dal80pr-GFP was re-transformed into top 43 strains that
overexpress GFP. Four hour induction is shown for all 43 deletion
strains (top) and timecourse for top 8 strains (bottom).
Found at: doi:10.1371/journal.pgen.1000515.s001 (1.09 MB TIF)
Figure S2 Top forty strains that under-express Dal80pr-GFP
reporter (blue) and their corresponding induction of Gal1pr-GFP
(yellow). Strains that fail to induce both reporters are not efficient
in transcribing/translating GFP. Strains that express Gal1pr-GFP
normally, but fail to induce Dal80pr-GFP, are TOR specific.
Galactose induction was for 4 hours, rapamycin induction was for
15 hours.
Found at: doi:10.1371/journal.pgen.1000515.s002 (0.69 MB TIF)
Figure S3 npr2D, npr3D, and double mutant npr2Dnpr3D cells
were grown in YP (yeast extract+peptone) with various concen-
trations of glucose. No difference in growth was observed between
WT and mutants.
Found at: doi:10.1371/journal.pgen.1000515.s003 (0.60 MB TIF)
Figure S4 Npr2 and Npr3 appear to co-purify with each other.
Npr3-TAP strains demonstrate a band where Npr2 migrates and
Npr2-TAP demonstrates a band where Npr3 migrates. TAP
purification was performed under standard procedures with
5 liters of OD600=1 cells. Shown is a silver stain of purifications.
Found at: doi:10.1371/journal.pgen.1000515.s004 (2.30 MB TIF)
Figure S5 Npr2 and Npr3 are evolutionarily conserved among
eukaryotes, but not present in bacteria. Npr3 is also listed as
Rmd11 in Saccharomyces Genome Database (http://www.
yeastgenome.org).
Found at: doi:10.1371/journal.pgen.1000515.s005 (0.51 MB TIF)
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